Quinoline

Quinoline

SCHEMBL3629028

C1CNCCN1.c1ccc2ncccc2c1

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Quinoline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.74
NPC1 O15118 1/20 0.47
POLB P06746 1/20 0.47
RAB9A P51151 1/20 0.47
CYP3A4 P08684 4/20 0.46
HTT P42858 3/20 0.46
KDM4E B2RXH2 3/20 0.46
CYP1A2 P05177 3/20 0.46
HSD17B10 Q99714 2/20 0.46
HTR2C P28335 2/20 0.46
SLC6A4 P31645 2/20 0.46
HTR3E A5X5Y0 1/20 0.46
USP2 O75604 1/20 0.46
HTR3B O95264 1/20 0.46
ADRB1 P08588 1/20 0.46
HTR1A P08908 1/20 0.46
MAPK1 P28482 1/20 0.46
HTR7 P34969 1/20 0.46
HTR3A P46098 1/20 0.46
HTR6 P50406 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quinoline SCHEMBL27309468 1.00 ALDH1A1 (0.74) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL28192494 0.98 ALDH1A1 (0.71) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL28274774 0.98 ALDH1A1 (0.71) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL27731962 0.92 ALDH1A1 (0.63) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL27282295 0.92 ALDH1A1 (0.68) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL20473420 0.92 ALDH1A1 (0.68) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL28159418 0.91 ALDH1A1 (0.74) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL27914505 0.91 ALDH1A1 (0.61) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL28231211 0.91 ALDH1A1 (0.61) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL27553399 0.91 ALDH1A1 (0.61) ALDH1A1NPC1POLBRAB9ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 188 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112390751-A Toll-like receptor-7 small molecule inhibitor and preparation method thereof 清华大学 2021-02-23 CN claimed
CN-109384780-A Tetrahydro-proto-berberine compounds, preparation method, purposes and pharmaceutical composition 中国科学院上海药物研究所 2019-02-26 CN claimed
CN-104193609-B 1, 4-naphthoquinone derivatives and therapeutic uses thereof 国家科研中心 2017-04-12 CN claimed
CN-105294685-B Hexahydropyrazine quinolines D3 receptors ligand and its production and use 东南大学 2017-03-08 CN claimed
CN-105189506-A Compounds and compositions for the treatment of parasitic diseases NOVARTIS AG 2015-12-23 CN claimed
CN-101272777-B Stable dosage forms of spiro and dispiro 1,2, 4-trioxolane antimalarials RANBAXY LAB LTD 2013-01-30 CN claimed
CN-102558048-A Polycrystal substance of piperaquine phosphate and preparation method thereof ZHUHAI RUNDU PHARMACEUTICAL CO LTD 2012-07-11 CN claimed
CN-101440063-B Preparation of piperaquini phosphatis CHONGQING KANGLE PHARMACEUTICAL CO LTD 2011-07-13 CN claimed
CN-102015607-A 1, 4-naphthoquinone derivatives and therapeutic uses thereof CENTRE NAT RECH SCIENT 2011-04-13 CN claimed
CN-101466680-A Process for synthesizing piperazine-piperidine compounds WYETH CORP (US) 2009-06-24 CN claimed
CN-101440063-A Preparation of piperaquini phosphatis CHONGQING KANGLE PHARMACEUTICA (CN) 2009-05-27 CN claimed
CN-100448051-C Organic electroluminescence device UNIV TSINGHUA (CN) 2008-12-31 CN claimed
CN-101272777-A Stable dosage forms of spiro and dispiro 1,2, 4-trioxolane antimalarials RANBAXY LAB LTD (IN) 2008-09-24 CN claimed
CN-1320001-C Novel polyvinyl esters CELANESE VENTURES GMBH (DE) 2007-06-06 CN claimed
CN-1678645-A Novel polyvinyl esters CELANESE VENTURES GMBH (DE) 2005-10-05 CN claimed
CN-1564641-A Organic electroluminescence device UNIV TSINGHUA (CN) 2005-01-12 CN claimed
CN-1161002-C Organic electroluminescent device 清华大学 2004-08-04 CN claimed
CN-1457105-A Organic electroluminescent device UNIV TSINGHUA (CN) 2003-11-19 CN claimed
CN-1035286-A The amino acid derivative of renin-inhibiting HOECHST AG (DE) 1989-09-06 CN claimed
WO-2024049718-A3 QUINOLINE PIPERAZINE DERIVATIVES, PHARMACEUTICAL COMPOSITION AND USES THEREOF IMMUNOCURE INC. (US) 2024-04-04 WO disclosed
WO-2024049718-A2 QUINOLINE PIPERAZINE DERIVATIVES, PHARMACEUTICAL COMPOSITION AND USES THEREOF IMMUNOCURE INC. (US) 2024-03-07 WO disclosed
WO-2024049718-A2 QUINOLINE PIPERAZINE DERIVATIVES, PHARMACEUTICAL COMPOSITION AND USES THEREOF IMMUNOCURE INC. (US) 2024-03-07 WO disclosed
CN-116615428-A Tricyclic pyridones and pyrimidinones 医睿世康药业研发公司 2023-08-18 CN disclosed
EP-4217071-A1 TRICYCLIC PYRIDONES AND PYRIMIDONES Erasca, Inc. (US) 2023-08-02 EP disclosed
US-20230203063-A1 TRICYCLIC PYRIDONES AND PYRIMIDONES ERASCA, INC. 2023-06-29 US disclosed
CN-112390751-B Toll-like receptor-7 small molecule inhibitor and preparation method thereof 清华大学 2022-07-05 CN disclosed
US-20220119409-A1 TRICYCLIC PYRIDONES AND PYRIMIDONES ERASCA, INC. 2022-04-21 US disclosed
US-11279696-B2 Processes for the preparation of 7-{4-[4-(1-benzothiophen-4-yl) piperazin-1-yl]butoxy}quinolin-2(1H)-one MSN LABORATORIES PRIVATE LIMITED (IN) 2022-03-22 US disclosed
CN-110606830-B Method for producing piperaquine phosphate intermediate quinoline piperazine hydrochloride by applying piperazine 珠海润都制药股份有限公司 2022-03-18 CN disclosed
WO-2021127404-A1 TRICYCLIC PYRIDONES AND PYRIMIDONES ERASCA, INC. (US) 2021-06-24 WO disclosed
CN-112390751-A Toll-like receptor-7 small molecule inhibitor and preparation method thereof 清华大学 2021-02-23 CN disclosed
WO-2020183011-A1 HTR1D INHIBITORS AND USES THEREOF IN THE TREATMENT OF CANCER INSTITUT CURIE (FR) 2020-09-17 WO disclosed
CN-110606830-A Method for producing piperaquine phosphate intermediate quinoline piperazine hydrochloride by applying piperazine 珠海润都制药股份有限公司 2019-12-24 CN disclosed
CN-110536889-A Atazanavir (ATV) analogs for the treatment of HIV infection GILEAD SCIENCES INC 2019-12-03 CN disclosed
CN-209696598-U A kind of device recycling vacuum tail gas in triethyl orthoformate production process FUSHUN SHUNTE CHEMICAL CO LTD 2019-11-29 CN disclosed
CN-107405870-B Laminated body, temporary bond composition and temporary bond film 富士胶片株式会社 2019-11-19 CN disclosed
CN-110267649-A Immunomodulatory compounds 兰肯瑙医学研究所 2019-09-20 CN disclosed
CN-109970639-A The method of piperaquine intermediate is synthesized in a kind of continuous current micro-reactor 重庆康乐制药有限公司 2019-07-05 CN disclosed
CN-106098722-B A kind of image sensing device and preparation method thereof and application method 清华大学 2019-07-02 CN disclosed
CN-109928997-A Electroluminescent organic material and device 环球展览公司 2019-06-25 CN disclosed
CN-107847398-B Control the pharmaceutical dosage form of release 南京三迭纪医药科技有限公司 2019-05-07 CN disclosed
CN-109476626-A Compound, material for organic electroluminescent element, and electronic device 出光兴产株式会社 2019-03-15 CN disclosed
CN-109384780-A Tetrahydro-proto-berberine compounds, preparation method, purposes and pharmaceutical composition 中国科学院上海药物研究所 2019-02-26 CN disclosed
CN-109180441-A A kind of synthetic method of triethyl orthoformate 江苏远大仙乐药业有限公司 2019-01-11 CN disclosed
CN-109152763-A Artesunate-containing composition 赵鸣 2019-01-04 CN disclosed
CN-109010916-A Containing the mouldable preparation of aerobic sterol in acellular tissue matrices 华沙整形外科股份有限公司 2018-12-18 CN disclosed
CN-108883119-A The method of separation and detection oxidation sterol 华沙整形外科股份有限公司 2018-11-23 CN disclosed
CN-108721242-A Pharmaceutical formulation and its use 南京三迭纪医药科技有限公司 2018-11-02 CN disclosed
CN-108699005-A 3- (carboxy ethyl) -8- amino -2- oxo -1,3- aza-spiros-[4.5]Decane derivative 格吕伦塔尔有限公司 2018-10-23 CN disclosed
CN-108653221-A Pharmaceutical formulation and its use 南京三迭纪医药科技有限公司 2018-10-16 CN disclosed
CN-108602777-A 3- ((miscellaneous -) aryl)-alkyl -8- amino -2- oxos -1,3- aza-spiro-[4.5]-decane derivative 格吕伦塔尔有限公司 2018-09-28 CN disclosed
CN-103842818-B Rapid fluorescent labeling of glycans and other biomolecules with enhanced MS signal 沃特世科技公司 2018-09-21 CN disclosed
CN-103728805-B Display particle dispersion, display medium and display device 电子墨水公司 2018-09-11 CN disclosed
CN-108495853-A COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CRYPTOSPORIDIOSIS 诺华股份有限公司 2018-09-04 CN disclosed
CN-108456250-A Target antibody and its application of IL-13RA2 科济生物医药(上海)有限公司 2018-08-28 CN disclosed
CN-108203367-A A kind of synthetic method of triethyl orthoformate 青岛祥智电子技术有限公司 2018-06-26 CN disclosed
CN-105790732-B A kind of multiple signals stacking apparatus 清华大学 2018-05-29 CN disclosed
WO-2018087775-A1 PROCESSES FOR THE PREPARATION OF 7-{4-[4-(1-BENZOTHIOPHEN-4-YL)PIPERAZIN-1-YL]BUTOXY}QUINOLIN-2(1H)-ONE MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) 2018-05-17 WO disclosed
CN-107922339-A Platelet storage methods and compositions for use in said methods 儿童医院医学中心 2018-04-17 CN disclosed
CN-107921113-A Immunomodulatory compositions and methods of use thereof 巴比塔·阿格拉沃尔 2018-04-17 CN disclosed
CN-103387583-B Diaryl simultaneously [a, g] quinolizine class compound, its preparation method, pharmaceutical composition and its application 中国科学院上海药物研究所 2018-04-13 CN disclosed
CN-107867983-A A kind of synthetic method of triethyl orthoformate 青岛九洲千和机械有限公司 2018-04-03 CN disclosed
CN-107847398-A The pharmaceutical dosage form of control release 南京三迭纪医药科技有限公司 2018-03-27 CN disclosed
CN-107778287-A A kind of compound as tyrosine protein kinase inhibitor 南昌弘益药业有限公司 2018-03-09 CN disclosed
CN-206934352-U Pharmaceutical formulation 南京三迭纪医药科技有限公司 2018-01-30 CN disclosed
CN-104025265-B Polishing composition 福吉米株式会社 2018-01-12 CN disclosed
CN-107496574-A A kind of Chinese medicine preparation for treating cough and preparation method thereof 合肥川迪医药技术有限公司 2017-12-22 CN disclosed
CN-107405870-A Layered product, temporary bond composition and temporary bond film 富士胶片株式会社 2017-11-28 CN disclosed
CN-107383058-A Preparation of marbofloxacin 海门慧聚药业有限公司 2017-11-24 CN disclosed
CN-105646277-B Quinone derivative and electrophotographic photoreceptor 京瓷办公信息系统株式会社 2017-10-24 CN disclosed
CN-105339370-B Compound and and its pharmaceutical composition for treating diseases associated with inflammation 加拉帕戈斯股份有限公司 2017-09-15 CN disclosed
CN-107108485-A KCNQ 2-5 channel activator 小野药品工业株式会社 2017-08-29 CN disclosed
CN-107111253-A Organic processing liquid and pattern forming method 富士胶片株式会社 2017-08-29 CN disclosed
CN-107001360-A 4H-pyrido [1,2-a ] pyrimidin-4-one compounds 普拉纳生物技术有限公司 2017-08-01 CN disclosed
CN-105198884-B Pentacyclic indole quinolizine that the G1/G0 phases block, its synthesis, antitumor activity and application 首都医科大学 2017-08-01 CN disclosed
CN-104610774-B Second nonlinear optic compound and the nonlinear optical element containing it 独立行政法人情报通信研究机构 2017-07-18 CN disclosed
CN-106699524-A Synthetic method of triethyl orthoformate 青岛森美克化工技术有限公司 2017-05-24 CN disclosed
CN-104022135-B Optical coupler and preparation method for same 清华大学 2017-05-03 CN disclosed
CN-206120770-U Medicine formulation 南京三迭纪医药科技有限公司 2017-04-26 CN disclosed
CN-206120771-U Medicine formulation 南京三迭纪医药科技有限公司 2017-04-26 CN disclosed
CN-105164124-B Compounds and compositions for treating parasitic diseases 诺华股份有限公司 2017-03-15 CN disclosed
CN-106414410-A Molecules having certain pesticidal utility, and intermediates, compositions, and methods related thereto 美国陶氏益农公司 2017-02-15 CN disclosed
EP-2718268-B1 NOVEL PROCESS FOR THE SYNTHESIS OF 7-CHLORO-4-(PIPERAZIN-1-YL)-QUINOLINE SIGMA TAU IND FARMACEUTI (IT) 2016-12-28 EP disclosed
CN-103289432-B Electrophoresis particle, electrophoretic particle dispersion liquid, display medium and display device 富士施乐株式会社 2016-12-28 CN disclosed
CN-103664974-B Aryl [a] indole [2,3-g] quinolizine compounds, its preparation method, pharmaceutical composition and application thereof 中国科学院上海药物研究所 2016-12-21 CN disclosed
CN-104557973-B 3,3 '-methylene of a kind of chirality piperazine quinoline ring-bis-fluoro quinolone derivatives and its preparation method and application 河南大学 2016-11-23 CN disclosed
CN-104557973-B 3,3 '-methylene of a kind of chirality piperazine quinoline ring-bis-fluoro quinolone derivatives and its preparation method and application 河南大学 2016-11-23 CN disclosed
CN-106133601-A Sensitized ray or the manufacture method of radiation-sensitive resin composition, sensitized ray or radiation-sensitive resin composition, sensitized ray or radioactivity-sensitive film, possess sensitized ray or the blank mask of radioactivity-sensitive film, photomask, pattern formation method, the manufacture method of electronic device and electronic device 富士胶片株式会社 2016-11-16 CN disclosed
CN-106098722-A A kind of image sensing device and preparation method thereof and using method 清华大学 2016-11-09 CN disclosed
CN-106045936-A COMPOSITIONS, SYNTHESIS, AND METHODS OF UTILIZING ARYLPIPERAZINE DERIVATIVES 雷维瓦药品公司 2016-10-26 CN disclosed
CN-106008500-A Corynantheidine compounds and preparation method thereof 复旦大学 2016-10-12 CN disclosed
CN-104053675-B Low anticoagulant heparin 迪乐方特有限责任公司 2016-10-12 CN disclosed
CN-102796096-B Hexahydro dibenzo [a, g] quinolizine compounds, its preparation method, pharmaceutical composition and application thereof 中国科学院上海药物研究所 2016-09-14 CN disclosed
CN-105934458-A Polymerizable composition for optical material, optical material obtained from the composition, and plastic lens 三井化学株式会社 2016-09-07 CN disclosed
CN-105790732-A Multipath signal superposition device 清华大学 2016-07-20 CN disclosed
CN-103579282-B Integrated optocoupler of a kind of multichannel and preparation method thereof TSINGHUA UNIVERSITY (CN) 2016-04-06 CN disclosed
CN-103483165-B Prepare the green cleaning procedure of ortho-formiate HEBEI CHENGXIN CO., LTD. (CN) 2016-02-24 CN disclosed
CN-105189506-A Compounds and compositions for the treatment of parasitic diseases NOVARTIS AG 2015-12-23 CN disclosed
CN-105164124-A Compounds and compositions for treating parasitic diseases NOVARTIS AG 2015-12-16 CN disclosed
US-9206133-B2 Process for the synthesis of 7-chloro-4-(piperazin-1-yl)-quinoline SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2015-12-08 US disclosed
CN-104755083-A Urea and amide derivatives of aminoalkylpiperazines and use thereof SOUTHERN RES INST 2015-07-01 CN disclosed
CN-103664552-B Synthesis method for triethyl orthoformate ZHAO YIFAN 2015-06-10 CN disclosed
CN-104684396-A Tricyclic tetrahydroquinoline antibacterial agents ZOETIS LLC 2015-06-03 CN disclosed
CN-102898428-B Microwave synthesis method of spirocyclopiperazinium compound UNIV CHANGZHOU 2015-04-22 CN disclosed
US-8951988-B2 Azidothymidine quinoline conjugated compound, preparation method therefor and application thereof in anti-hepatoma therapy HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2015-02-10 US disclosed
US-20140256670-A1 AZIDOTHYMIDINE QUINOLINE CONJUGATED COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN ANTI-HEPATOMA THERAPY HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2014-09-11 US disclosed
CN-104022135-A Optical coupler and preparation method for same UNIV TSINGHUA 2014-09-03 CN disclosed
US-20140200346-A1 Novel Process for the Synthesis of 7-Chloro-4-(piperazin-1-yl)-quinoline SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2014-07-17 US disclosed
EP-2718268-A2 NOVEL PROCESS FOR THE SYNTHESIS OF 7-CHLORO-4-(PIPERAZIN-1-YL)-QUINOLINE Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. (IT) 2014-04-16 EP disclosed
CN-103664552-A Synthesis method for triethyl orthoformate ZHAO YIFAN 2014-03-26 CN disclosed
CN-103596927-A Novel process for the synthesis of 7-chloro-4-(piperazin-1-yl)-quinoline SIGMA TAU IND FARMACEUTI 2014-02-19 CN disclosed
CN-103579282-A Multi-channel integrated optical couplers and method for manufacturing same UNIV TSINGHUA 2014-02-12 CN disclosed
CN-103483165-A Green process for preparing orthoformate Hebei chengxin co ltd 2014-01-01 CN disclosed
CN-103041838-A Catalyst for preparing 2, 6-dichlorobenzonitrile from 2, 6-dichlorotoluene by means of ammoxidation WUHAN JINFU TECHNOLOGY CO LTD 2013-04-17 CN disclosed
CN-101272777-B Stable dosage forms of spiro and dispiro 1,2, 4-trioxolane antimalarials RANBAXY LAB LTD 2013-01-30 CN disclosed
CN-102898428-A Microwave synthesis method of spirocyclopiperazinium compound UNIV CHANGZHOU 2013-01-30 CN disclosed
WO-2012168213-A2 NOVEL PROCESS FOR THE SYNTHESIS OF 7-CHLORO-4-(PIPERAZIN-1-YL)-QUINOLINE SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2012-12-13 WO disclosed
CN-102822746-A Pattern forming method and resist composition FUJIFILM CORP 2012-12-12 CN disclosed
CN-102812400-A Actinic ray-sensitive or radiation-sensitive resin composition and pattern forming method using same FUJIFILM CORP 2012-12-05 CN disclosed
CN-102812006-A New anti-malarial agents MEDICINES FOR MALARIA VENTURE MMV 2012-12-05 CN disclosed
CN-102558048-A Polycrystal substance of piperaquine phosphate and preparation method thereof ZHUHAI RUNDU PHARMACEUTICAL CO LTD 2012-07-11 CN disclosed
CN-102395565-A Compounds having antiparasitic or anti-infectious activity UNIV OREGON HEALTH & SCIENCE (US) 2012-03-28 CN disclosed
CN-202145468-U Flexible organic electroluminescent device BOE TECHNOLOGY GROUP CO LTD 2012-02-15 CN disclosed
US-8071768-B2 Alkylquinoline and alkylquinazoline kinase modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2011-12-06 US disclosed
CN-101575327-B Antimalarial active isocumarans compound and composition, preparation method and application thereof GUANGZHOU INST BIOMED & HEALTH 2011-09-14 CN disclosed
CN-101440063-B Preparation of piperaquini phosphatis CHONGQING KANGLE PHARMACEUTICAL CO LTD 2011-07-13 CN disclosed
CN-102015607-A 1, 4-naphthoquinone derivatives and therapeutic uses thereof CENTRE NAT RECH SCIENT 2011-04-13 CN disclosed
CN-102015711-A Spiro-indole derivatives for the treatment of parasitic diseases NOVARTIS AG 2011-04-13 CN disclosed
US-7825244-B2 Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis JANSSEN PHARMACEUTICA NV (BE) 2010-11-02 US disclosed
CN-101842377-A Two spiral shells 1,2,4-trioxa pentamethylene antimalarial drug MEDICINES MALARIA VENTURE MMV 2010-09-22 CN disclosed
CN-101240344-B Plasmodium falciparum medicament resistance related gene polymorphism detecting chip and application thereof NAT INST FOR PARASITIC DISEASES CHINESE CT FOR DISEASE CONTROL AND PREVENTION 2010-09-08 CN disclosed
CN-101783358-A Organic optical coupler component UNIV TSINGHUA 2010-07-21 CN disclosed
CN-1689186-B Proton conducting membrane and application thereof BASF FUEL CELL GMBH 2010-06-16 CN disclosed
CN-201373373-Y Brick lamp KUNSHAN VISIONOX DISPLAY TECH 2009-12-30 CN disclosed
CN-101575327-A Antimalarial active isocumarans compound and composition, preparation method and application thereof CHINESE ACADEMY OF SCIENCES GU (CN) 2009-11-11 CN disclosed
CN-101466680-A Process for synthesizing piperazine-piperidine compounds WYETH CORP (US) 2009-06-24 CN disclosed
CN-101442043-A Organic light coupling device UNIV TSINGHUA (CN) 2009-05-27 CN disclosed
CN-101440063-A Preparation of piperaquini phosphatis CHONGQING KANGLE PHARMACEUTICA (CN) 2009-05-27 CN disclosed
WO-2008067390-A9 METABOLITES OF 5-FLUORO-8-{4-[4-(6-METHOXYQUINOLIN-8-YL)PIPERAZIN-1-YL]PIPERIDIN-1-YL} QUINOLINE AND METHODS OF PREPARATION AND USES THEREOF WYETH CORP (US) 2009-05-22 WO disclosed
CN-100484353-C Organic electroluminescent part TSINGHUA UNIVERSITY KUNSHAN VI (CN) 2009-04-29 CN disclosed
CN-101392101-A Processed pigment, pigment-dispersed composition, colored photosensitive composition, color filter, liquid crystal display element, and solid image pickup element FUJIFILM CORP (JP) 2009-03-25 CN disclosed
CN-101394696-A Organic EL device UNIV TSINGHUA (CN) 2009-03-25 CN disclosed
CN-100448051-C Organic electroluminescence device UNIV TSINGHUA (CN) 2008-12-31 CN disclosed
CN-101300249-A Aminoquinoline and aminoquinazoline kinase modulators JANSSEN PHARMACEUTICA NV (BE) 2008-11-05 CN disclosed
CN-101293871-A 7-chlorine-4-[4'-(7''-chloroquine-4''-base)diethylenediamine-1'-base]quinoline and uses thereof INST OF TROPICAL MEDICINE OF G (CN) 2008-10-29 CN disclosed
US-20080262228-A1 Metabolites of 5-fluoro-8- quinoline and methods of preparation and uses thereof WYETH (US) 2008-10-23 US disclosed
CN-101289423-A 7-chlorine -4-(1- piperazinyl)chinoline and applications thereof in preparation of anti-malaria medicaments INST OF TROPICAL MEDICINE OF G (CN) 2008-10-22 CN disclosed
CN-101272777-A Stable dosage forms of spiro and dispiro 1,2, 4-trioxolane antimalarials RANBAXY LAB LTD (IN) 2008-09-24 CN disclosed
CN-101243065-A Intermediates for the synthesis of alkylquinoline and alkylquinazoline kinase modulators and related synthetic methods JANSSEN PHARMACEUTICA NV (BE) 2008-08-13 CN disclosed
CN-101240344-A Plasmodium falciparum medicament resistance related gene polymorphism detecting chip and application thereof NAT INST FOR PARASITIC DISEASE (CN) 2008-08-13 CN disclosed
CN-101237731-A An organic EL part UNIV TSINGHUA (CN) 2008-08-06 CN disclosed
WO-2008067390-A2 METABOLITES OF 5-FLUORO-8-{4-[4-(6-METHOXYQUINOLIN-8-YL)PIPERAZIN-1-YL]PIPERIDIN-1-YL} QUINOLINE AND METHODS OF PREPARATION AND USES THEREOF WYETH (US) 2008-06-05 WO disclosed
EP-1893598-A1 ALKYLQUINOLINE AND ALKYLQUINAZOLINE KINASE MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2008-03-05 EP disclosed
EP-1891040-A1 INTERMEDIATES USEFUL IN THE SYNTHESIS OF ALKYLQUINOLINE AND ALKYLQUINAZOLINE KINASE MODULATORS AND RELATED METHODS OF SYNTHESIS JANSSEN PHARMACEUTICA N.V. (BE) 2008-02-27 EP disclosed
CN-100340024-C Membrane electrode unit comprising a polyimide layer PEMEAS GMBH (DE) 2007-09-26 CN disclosed
CN-1320001-C Novel polyvinyl esters CELANESE VENTURES GMBH (DE) 2007-06-06 CN disclosed
CN-1315836-C 2- (quinolonyl) -fused heterocycles as androgen receptor modulators ORTHO MCNEIL PHARM INC (US) 2007-05-16 CN disclosed
CN-1297588-C Polymer film based on polyazoles, and use thereof PEMEAS GMBH (DE) 2007-01-31 CN disclosed
US-20070021436-A1 INTERMEDIATES USEFUL IN THE SYNTHESIS OF ALKYLQUINOLINE AND ALKYLQUINAZOLINE KINASE MODULATORS, AND RELATED METHODS OF SYNTHESIS JANSSEN PHARMACEUTICA, N.V. (BE) 2007-01-25 US disclosed
CN-1897311-A Organic optical coupler device UNIV TSINGHUA (CN) 2007-01-17 CN disclosed
US-20070004763-A1 AMINOQUINOLINE AND AMINOQUINAZOLINE KINASE MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2007-01-04 US disclosed
WO-2006135646-A1 INTERMEDIATES USEFUL IN THE SYNTHESIS OF ALKYLQUINOLINE AND ALKYLQUINAZOLINE KINASE MODULATORS AND RELATED METHODS OF SYNTHESIS JANSSEN PHARMACEUTICA N.V. (BE) 2006-12-21 WO disclosed
WO-2006135721-A1 ALKYLQUINOLINE AND ALKYLQUINAZOLINE KINASE MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2006-12-21 WO disclosed
US-20060281772-A1 ALKYLQUINOLINE AND ALKYLQUINAZOLINE KINASE MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2006-12-14 US disclosed
CN-1826116-A Piperidine derivatives as melanocortin-4 receptor agonists MERCK & CO INC (US) 2006-08-30 CN disclosed
CN-1689186-A Proton conducting membrane and application thereof PEMEAS GMBH (DE) 2005-10-26 CN disclosed
CN-1678645-A Novel polyvinyl esters CELANESE VENTURES GMBH (DE) 2005-10-05 CN disclosed
CN-1678663-A Polypyrrole-based polymer membranes and their use PEMEAS GMBH (DE) 2005-10-05 CN disclosed
CN-1675788-A Membrane electrode assembly comprising polyimide layer PEMEAS GMBH (DE) 2005-09-28 CN disclosed
CN-1662540-A 2- (quinolonyl) -fused heterocycles as androgen receptor modulators ORTHO MCNEIL PHARM INC (US) 2005-08-31 CN disclosed
CN-1205185-C Nitrogen-containing cyclic compound and pharmaceutical composition containing the same EISAI CO LTD (JP) 2005-06-08 CN disclosed
US-20050107372-A1 2-(Quinolonyl)-fused heterocycles as androgen receptor modulators LANTER JAMES C (US) 2005-05-19 US disclosed
CN-1191254-C Fused pyrrole compounds, pharmaceutical composition containing the same, and the use thereof MARCKLE GMBH (DE) 2005-03-02 CN disclosed
US-6858621-B2 2-(quinolonyl)-fused heterocycles as androgen receptor modulators ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2005-02-22 US disclosed
EP-1501835-A2 2-(QUINOLONYL)-FUSED HETEROCYCLES AS ANDROGEN RECEPTOR MODULATORS Ortho-Mcneil Pharmaceutical, Inc. (US) 2005-02-02 EP disclosed
CN-1564641-A Organic electroluminescence device UNIV TSINGHUA (CN) 2005-01-12 CN disclosed
US-20040014743-A1 2-(Quinolonyl)-fused heterocycles as androgen receptor modulators ORTHO-MCNEIL PHARMACEUTICAL, INC. 2004-01-22 US disclosed
WO-2003090672-A2 2-(QUINOLONYL)-FUSED HETEROCYCLES AS ANDROGEN RECEPTOR MODULATORS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2003-11-06 WO disclosed
CN-1418217-A Fused pyrrole compounds, pharmaceutical composition containing the same, and the use thereof MARCKLE GMBH (DE) 2003-05-14 CN disclosed
CN-1395562-A Nitrogenous cyclic compounds and pharmaceutical compositions containing the same EISAI CO LTD (JP) 2003-02-05 CN disclosed
CN-1315858-A Novel remedies for allergic diseases FUJI YAKUHIN KOGYO KK (JP) 2001-10-03 CN disclosed
CN-1052232-C 3N-alkyl-3,4-dihydro-2H-4-substituted heteroaromatic azyl-7,8,9,10(7,10)-naphthane-(2,1-e)-(1,3) MICROORGANISM EPIDEMIC INST MI (CN) 2000-05-10 CN disclosed
CN-1034331-C Amines and their use MITSUI PHARMACEUTICALS LTD (JP) 1997-03-26 CN disclosed
CN-1097422-A 3-N-alkyl-3,4-dihydro-amino-7,8,9,10 (7,10)-four (two) the hydrogen naphtho-s of the assorted virtue of 2H-4-replacement-(2,1-e)-(1,3) oxazine derivative MICROORGANISM EPIDEMIC INST MI (CN) 1995-01-18 CN disclosed
CN-1014789-B PROCESS FOR PREPARING REPLACABLE BRIDGED HEAVY NITROGEN BICYCLOALKYL CARBOSTYRIL CARBOXYLIC ACID PFIZER (US) 1991-11-20 CN disclosed
CN-1054718-A Collyrium CHINOIN GYOGYSZER ES VEGYESZET (HU) 1991-09-25 CN disclosed
CN-85100781-B Preparation method of artesunate as antimalarial 广西壮族自治区桂林制药厂 1988-07-06 CN disclosed
CN-86106385-A The bridge-type diazonium bicyclic alkyl quinolone carboxylic acid that replaces 1987-06-03 CN disclosed
CN-86106385-A The bridge-type diazonium bicyclic alkyl quinolone carboxylic acid that replaces 1987-06-03 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040014743-A1 2-(Quinolonyl)-fused heterocycles as androgen receptor modulators AR, NR5A1, ESRRA ALDH1A1 708/4885NPC1 1618/4885POLB 2475/4885
US-20070021436-A1 INTERMEDIATES USEFUL IN THE SYNTHESIS OF ALKYLQUINOLINE AND ALKYLQUINAZOLINE KINASE MODULATORS, AND RELATED METHODS OF SYNTHESIS FLT3, ABL1, KIT ALDH1A1 2867/4885NPC1 4264/4885POLB 3499/4885
US-20230203063-A1 TRICYCLIC PYRIDONES AND PYRIMIDONES TYMS, TYMP, DHFR ALDH1A1 547/4885NPC1 3090/4885POLB 329/4885
US-20220119409-A1 TRICYCLIC PYRIDONES AND PYRIMIDONES DHFR, TYMS, TYMP ALDH1A1 564/4885NPC1 3126/4885POLB 432/4885
US-20140256670-A1 AZIDOTHYMIDINE QUINOLINE CONJUGATED COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN ANTI-HEPATOMA THERAPY GOT1, WEE1, HCCS ALDH1A1 687/4885NPC1 1601/4885POLB 1703/4885
US-20050107372-A1 2-(Quinolonyl)-fused heterocycles as androgen receptor modulators AR, NR5A1, CYP19A1 ALDH1A1 886/4885NPC1 2200/4885POLB 2417/4885
US-20060281772-A1 ALKYLQUINOLINE AND ALKYLQUINAZOLINE KINASE MODULATORS FLT3, KIT, NTRK2 ALDH1A1 2024/4885NPC1 2872/4885POLB 2073/4885
US-20070004763-A1 AMINOQUINOLINE AND AMINOQUINAZOLINE KINASE MODULATORS FLT3, BMX, ABL1 ALDH1A1 3033/4885NPC1 3833/4885POLB 1726/4885
US-11279696-B2 Processes for the preparation of 7-{4-[4-(1-benzothiophen-4-yl) piperazin-1-yl]butoxy}quinolin-2(1H)-one CYP1B1, CYP4B1, CYP1A1 ALDH1A1 244/4885NPC1 1265/4885POLB 870/4885
US-20140200346-A1 Novel Process for the Synthesis of 7-Chloro-4-(piperazin-1-yl)-quinoline CYP3A7, UGT1A7, RAB7A ALDH1A1 539/4885NPC1 578/4885POLB 236/4885
US-20080262228-A1 Metabolites of 5-fluoro-8- quinoline and methods of preparation and uses thereof UGT1A8, CYP2C8, NQO1 ALDH1A1 416/4885NPC1 298/4885POLB 3398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.